Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ @t8{pb;v
M5]$w]Ny9
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© qp
]sVY
m=]}Tn
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ?:RWHe.P
T{ /\q 5
1.Co-stimulators (or co-stimulating molecules) E^m2:J]G
vu/P"?F
2.NK-kB jL~. =QD
mzTM&@
3.Immunoglobulin superfamily Wt!NLlN8
SvD:UG
4.antigen-presenting cell (APC) Y-*]6:{E
jiLt *>I
5.death domain cX48?srG
Pv3 e*I((
6.CCR and CXCR =]sM,E,n
.A<n2-
7.Lectin (or mitogen) /k^O1+]H
`,FvYA"
8.Clusters of differentiation, CD) h)yAge
MY>o8A
9.B7 family X1lL@ `r.5
eHI7= [h
10.Cytotoxic T lymphocyte, CTL) +?bOGUik
>J@hqW
11.IL-15 and IL-15 receptor (IL-15R) 8'Bik
OW8"7*irT
12.MHC restriction 7_AcvsdW
8E\6RjM
13.Affinity-chromatography z
T#j.v
KN zm)O
14.Cyctosprin A, CsA YW)&IA2
%NfbgJcL_
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ]abox%U=%
[|\BuUT'
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 0p'=Vel{}
IH0qx_;P&
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 Z
3
$3zyi
w>$2
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ X3;|h93.a
dD0:K3@
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ {(!j6|jK
?Wm.'S'to
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© L|[0&u!
mOvwdRKn
ÃâÒßѧרҵ£º hZ@Wl6FG;
@.Pe.\Z
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ 8_@#5
3<nd;@:-
Ïû»¯ÄÚ¿Æ£º i-4pdK u
4^mpQ.]lO
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ HO(9)sK
8}kY^"*&X
ѪҺ²¡Ñ§×¨Òµ£º {]w@s7E
|tU4(hC
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿